FdaApplication
ANDA 202047
Identifiers
- fda_app_no: ANDA202047
Properties
| Property | Value |
|---|---|
| applicant_name | PHARMAZONE |
| application_type | ANDA |
| approval_date | 2012-12-31 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| RIZATRIPTAN BENZOATE | RIZATRIPTAN BENZOATE | EQ 5MG BASE | TABLET;ORAL |
| RIZATRIPTAN BENZOATE | RIZATRIPTAN BENZOATE | EQ 10MG BASE | TABLET;ORAL |
2 products